The Chordoma Foundation and some of its philanthropic partners announced that they will launch a competition offering $500,000 in prizes for the discovery of drugs targeting the protein TBXT, a ...
James Kalyvas. Kalyvas confirmed that Williams had cancer — a sacral chordoma which is incredibly rare and develops slowly over time. The type of spinal cancer Williams was diagnosed with ...
James Kalyvas. Kalyvas confirmed that Williams had cancer — a sacral chordoma which is incredibly rare and develops slowly over time. Dr. James Kalyvas of Ochsner Hospital New Orleans.
The cancer in my back is stable and my other cancer is a little bit different,” Mellen explained. “I think I have chordoma and ependymoma, the chordoma is in my back, in my sacrum right now and my ...
Introduction: Cancer stem cells (CSCs), a group of tumor-initiating and tumor-maintaining cells, may be major players in the treatment resistance and recurrence distinctive of chordoma. Characterizing ...
NUC-7738 is under clinical development by NuCana and currently in Phase II for Chordoma. According to GlobalData, Phase II drugs for Chordoma does not have sufficient historical data to build an ...
NUC-7738 is under development for the treatment of solid tumors including metastatic cutaneous melanoma, metastatic lung adenocarcinoma, metastatic clival chordoma, B-cell non-Hodgkin lymphomas (NHL), ...